253
Participants
Start Date
August 25, 2017
Primary Completion Date
March 21, 2019
Study Completion Date
May 6, 2024
DS-8201a
DS-8201a is sterile lyophilized powder reconstituted into a sterile aqueous solution (100 mg/5 mL) to be administered as low, medium and high intravenous (IV) doses for Part 1 of the trial. The dose for Part 2 will be determined based on results from Part 1.
AZ Sint-Maarten, Mechelen
Imeldaziekenhuis, Bonheiden
UZ Leuven, Leuven
CHU Sart Tilman, Liège
Grand Hôpital de Charleroi, Charleroi
Hospital Infanta Cristina, Badajoz
Hospital Quiron Barcelona, Barcelona
Memorial Sloan Kettering Cancer Center, New York
National Cancer Center, Goyang-si
North Shore Hematology Oncology Associates PC DBA NY Cancer and Blood Specialists, East Setauket
Seoul National University Bundang Hospital, Seongnam-si
Hôpital Nord - CHU Marseille, Marseille
Allegheny General Hospital, Pittsburgh
UPMC Cancer Center, Pittsburgh
CH de la Rochelle - Hopital St Louis, La Rochelle
Ospedale San Raffaele, Milan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
IEO Istituto Europeo di Oncologia, Milan
Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo), Monza
Centre Georges François Leclerc, Dijon
Virginia Cancer Specialists, PC, Fairfax
CHU Besançon - Hôpital Jean Minjoz, Besançon
MD Anderson Cancer Centre, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario La Paz, Madrid
Hospital Clinico Universitario Virgen de la Victoria, Málaga
St Francis Hospital, Greenville
Piedmont Cancer Institute, Atlanta
Specialist Global Research, Hialeah
CHU Bordeaux - Hôpital Saint André, Gironde
Miami Cancer Institute at Baptist Health, Inc., Miami
Sylvester Comprehensive Cancer Center - Deerfield Beach, Boca Raton
Institut Régional du Cancer de Montpellier, Montpellier
CRLCC Eugene Marquis, Rennes
Norton Healthcare, Louisville
University of Louisville Research Foundation, Louisville
Hospital Universitario Virgen Macarena, Seville
Kyungpook National University Chilgok Hospital, Daegu
Centre Catherine de Sienne, Nantes
Aultman Hospital Cancer Center, Canton
University of Cincinnati Medical Center, Cincinnati
Instituto Valenciano de Oncologia IVO, Valencia
Ospedale degli Infermi, Rimini
Henry Ford Hospital, Detroit
Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Torrette
Washington University School of Medicine, St Louis
Centre Paul Strauss, Strasbourg
Centre Hospitalier Lyon Sud, Pierre-Bénite
Ochsner Clinic Foundation, New Orleans
Clinique Victor Hugo - Centre Jean Bernard, Le Mans
Texas Oncology, P.A., Dallas
Hôpital Saint-Louis - Paris, Paris
Texas Oncology, P.A. - Longview, Tyler
The University of Texas Health Science Center at Tyler, Tyler
Texas Oncology - Memorial City, Houston
MD Anderson Cancer Center, Houston
The Methodist Hospital Research Institute, Houston
Accurate Clinical Research, Baytown
Institut Sainte Catherine, Avignon
Arizona Oncology Associates, Tucson
The Regents of the University of California, Los Angeles
Innovative Clinical Research Institute, LLC, Whittier
Sharp Clinical Oncology Research, San Diego
Sansum Clinic, Santa Barbara
University of California San Francisco, San Francisco
Hôpital d'Instruction des Armees Begin, Saint-Mandé
Institut Gustave Roussy, Villejuif
Straub Medical Center, Honolulu
University of Hawaii, Honolulu
Providence Regional Medical Center - Everett, Everett
Alaska Urological Institute dba Alaska Clinical Research Center, Anchorage
Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston
University of Calgary, Calgary
NHO Shikoku Cancer Center, Matsuyama
Toranomon Hospital, Minatoku
Aichi Cancer Center Hospital, Aichi
National Cancer Center Hospital East, Chiba
NHO Kyushu Cancer Center, Fukuoka
Hakuaikai Sagara Hospital, Kagoshima
Kanagawa Cancer Center, Kanagawa
Kindai University Hospital, Osaka
National Cancer Center Hospital, Tokyo
St. Luke's International Hospital, Tokyo
Cancer Institute Hospital of JFCR, Tokyo
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital Universitari Quiron Dexeus, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
ICO l´Hospitalet - Hospital Duran i Reynals, Barcelona
Derriford Hospital, Plymouth
Queen Mary University of London, London
University College London Hospitals, London
Western General Hospital, Edinburgh
Nottingham University Hospitals City Campus, Nottingham
Royal Surrey County Hospital, Guildford
Lead Sponsor
Collaborators (2)
AstraZeneca
INDUSTRY
Daiichi Sankyo Co., Ltd.
INDUSTRY
Daiichi Sankyo
INDUSTRY